Dissociation between β2 microglobulin and IL-1 production in hemodialyzed patients

Nephrology Dialysis Transplantation

Volumn 12, Issue 11, 1997, Pages 2365-2374

  Carreno, M P ^a   Rousseau, Y ^a   Poignet, J L ^b   Jahns, G ^a   Cholley, B ^a   Kazatchkine, M D ^a   Haeffner Cavaillon, N ^a,c  

^a INSERM   (France)

^b Centre hospitalier E Rist   (France)

^c HÔPITAL BROUSSAIS   (France)

Author keywords

Amyloidosis; Biocompatibility; Cytokines; Hemodialysis; Leukocytes

Indexed keywords

AMYLOID; BETA 2 MICROGLOBULIN; CD14 ANTIGEN; COMPLEMENT COMPONENT C5A; ENDOTOXIN; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AMYLOIDOSIS; ARTICLE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTAMINATION; CONTROLLED STUDY; DIALYSATE; DIALYSIS MEMBRANE; HEMODIALYSIS; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UREMIA;

ADOLESCENT; ADULT; AMYLOIDOSIS; BETA 2-MICROGLOBULIN; HUMANS; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MIDDLE AGED; MONOCYTES; RENAL DIALYSIS;

EID: 0030721709     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.11.2365     Document Type: Article

References (52)

1. Gejyo F, Arakawa M. β2-microglobulin: Evidence for a new form of dialysis-associated amyloid protein. Kidney Int 1988; 33 [suppl. 24]: 30-31
2. Klinkmann H, Cambi V, Davison AM et al. Biocompatibility of hemodialysis systems: Present and future. Nephrol Dial Transpl 1991; 6 [suppl 2]: 514-520
3. Blumberg A, Burgi W. Behaviour of β2-microglobulin in patients with chronic renal failure undergoing hemodialysis hemodiafiltration and continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 1987; 27: 245-249
4. Nakazawa R, Hamaguchi K, Hasaka E et al. Synovial amyloidosis of β2-microglobulin type in patients undergoing longterm hemodialysis. Nephron 1986; 44: 379-380
5. Stone WJ, Hakim RM. β2-microglobulin amyloidosis in long term dialysis patients. Am J Nephrol 1989; 9: 177-183
6. Bommer J, Seelig P, Seeling R et al. Determinants of plasma β2-microglobulin: concentration: Possible relation to membrane biocompatibility. Nephrol Dial Transpl 1987; 2: 222-225
7. Kessler M, Netter P, Maheut et al. Highly permeable and biocompatible membranes and prevalence of dialysis-related arthropathy. Nephron 1990; 56: 455-456
8. Zaoui PM, Stone WJ, Hakim RM. Effects of dialysis membranes on beta-2-microglobulin production and cellular expression. Kidney Int 1990; 38: 962-968
9. Ryan JJ, Beynon HL, Rees AJ et al. In vitro production of tumor necrosis factor by monocytes cultured from dialysis patients. Kidney Int Suppl 1993; 41: 226-229
10. Girndt M, Kohler H, Schiedhelm-Weick E et al. Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int 1995; 47: 559-565
11. Friendlander MA, Hilbert CM, Wu YC et al. Role of dialysis modality in responses of blood monocytes and peritoneal macrophages to endotoxin stimulation. Am J Kidney Dis 1993; 22: 11-23
12. Schindler R, Marra MN, McKelligon BM et al. Plasma levels of bactericidal/permeability-increasing protein (BPI) and lipopolysacchatide-binding protein (LBP) during hemodialysis. Clin Nephrol 1993; 40: 346-351
13. Laude-Sharp M, Haeffner-Cavaillon N, Caroff M et al. Dissociation between the interleukin 1-inducing capacity and limulus reactivity of lipopolysacharides from gram-negative bacteria. Cytokine 1990; 2: 253-258
14. Bardin T, Zingraff J, Kuntz D et al. Dialysis related amyloidosis. Nephrol Dial Transpl 1986; 1: 151-154
15. Gaucher A, Kessler ML, Netter PA. Dialysis associated arthropathy. Can we prevent it? Can we be treated?. J Rheumatol 1992; 11: 1659-1662
16. Lebail-Darné JL, Bardin T, Zingraff J et al. The effect of renal transplantation on dialysis associated arthropathy. Rev Rhum 1994; 61: 89S-92S
17. Kessler M, Aymard B, Pourel J. Persistence of β2-microglobulin amyloid 10 years after the renal transplantation. Nephrol Dial Transpl 1994; 3: 333-334
18. Berland Y, Brunet Ph. β2-microglobulin amyloidosis and endotoxins. Rev. Rhum. 1994; 61: 85S-88S
19. Miyata T, Inagi R, Iida Y et al. Involvement of β2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1. J Clin Invest 1994; 93: 521-528
20. Pacciti A, Tetta C, Mangiarotti G et al. Beta-2-microglobulin serum profiles in different settings of mass transport and fluid pyrogen content, Kidney Int Suppl 1993; 41: S96-S99
21. Schaefer RM, Becker W, Denek et al. Sequestration of 111 indium-labelled granulocytes into the lung during hemodialysis J Nephrol 1990; 4: 235-239
22. Knudsen PJ, Leon J, Ak Ng et al. Hemodialysis-related induction of β2-microglobulin and interleukin-1 synthesis and release by mononuclear phagocytes. Nephron 1989; 53: 188-193
23. Pertosa G, Marfella C, Tarantino EA et al. Involvement of peripheral blood monocytes in haemodialysis: in vivo induction of TNFα, IL-6 and β2-microglobulin. Nephrol Dial Transpl 1991; 6 Suppl 2: 18-23
24. Cavaillon JM, Poignet JL, Fitting C et al. Serum IL-6 in long term hemodialyzed patients. Nephron 1992; 60(3): 307-313
25. Van Ypersele de Strihou C, Jadoul M, Malghem J et al. Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. Kidney Int 1991; 39: 1012-1019
26. Tucker SB, Pierre RY, Jordon RE. Rapid identification of monocytes in a mixt mononuclear cell preparation. J Immunol 1977; 14: 267-270
27. Haeffner-Cavaillon N, Cavaillon JM, Moreau M et al. Interleukin-1 secretion by human monocytes stimulated by the isolated polyssacharide region of the Bordella pertussis endotoxin. Mol Immunol 1984; 21: 389-395
28. Thiéblemont N, Weiss L, Sadeghi H et al. C141owCD16high: a cytokine-producing monocyte subset which expands during HIV infection. Eur J Immunol 1995; 25: 3418-3424
29. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159
30. Feuillard J, Gouy H, Bismuth G et al. NF-κB activation by tumor necrosis factor alpha in the Jurkat T cell line is independent of protein kinase A, protein kinase C, and Ca(2+)-regulated kinases. Cytokines 1991; 3: 257-265
31. Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kB. Proc Natl Acad Sci USA 1989; 86: 2336-2340
32. Bradford. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye-binding. Annal Biochem 1976; 72: 248-254
33. Couturier C, Jahns G, Kazatchkine MD et al. Membrane molecules which trigger the production of interleukin-1 and tumor necrosis factor-α by lipopolysaccharide-stimulated human monocytes. Eur J Immunol 1992; 22: 1461-1466
34. Charra B, Calemard E, Laurent G. Chronic renal failure treatment duration and mode. Their relevance to the late dialysis periarticular syndrome. Blood Purif 1988; 6: 117-124
35. Gejyo F, Homma N, Arakawa M. Carpal tunnel syndrome and β2-microglobulin related amyloidosis in chronic hemodialysis in chronic hemodialysis patients. Blood Purif 1988; 6: 125-131
36. Miyata T, Inaga R, Lida Y et al. Involvement of β2-microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 1993; 93: 521-528
37. Bertolini DR, Nedwin GE, Bringmn TS et al. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors. Nature 1986; 319: 516-518
38. Gowen M, Wood DD, Ihrie EJ et al. An interleukin 1 like factor stimulates bone resorption in vitro. Nature 1983; 306: 378-380
39. Poignet JL, Jahns G, Chauveau P et al. Induction by cytokines of β2-microglobulin production in cultured mononuclear from hemodialyzed patients. 24th Annual Meeting of the Am Soc Nephrol Abstract
40. Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994; 12: 141-179
41. Bingel M, Lonneman G, Koch KM et al. Plasma interleukin-1 activity during hemodialysis. The influence of dialysis membrane. Nephron 1988; 50: 273-276
42. Dinarello CA, Koch KM, Shaldon S. Interleukin-1 and its relevance in patients treated with hemodialysis. Kidney Inter 1988; 33 [suppl 24]: 21-26
43. Craddock PR, Fehr J, Dalmasso AP et al. Hemodialysis leukopenia: pulmonary vascular leukostasis resulting from complement activation by dialyser cellophane membranes. J Clin Invest 1977; 59: 879-888
44. Cheung AK, Henderson LW. Effects of complement activation by hemodialysis membranes. Am J Nephrol 1986; 6: 81-91
45. Wegmuller E, Montandon A, Nydegger UE et al. Biocompatibility of different hemodialysis membranes: activation of complement and leukopenia. Int J Art Organs 1986; 9: 85-92
46. Descamps-Latscha B, Goldfarb B, Nguyen AT et al. Establishing the relationship between complement activation and stimulation of phagocyte oxydative metabolism in hemodialyzed patients: A randomized prospective study. Nephron 1991; 59: 279-285
47. Hakim RM, Breillatt J, Lazarus JM et al. Complement activation and hypersensitivity reactions to dialysis membranes. Engl J Med 1984; 311: 878-882
48. Amadori A, Candi P, Sasdelli M et al. Hemodialysis leukopenia and complement function with different dialyzers. Kidney Int 1983; 24: 775-781
49. Cheung AK, Parker CJ, Wilcox LA et al. Activation of complement by hemodialysis membranes: polyacrylonitrile binds more C3a than cuprophane. Kidney Int 1990; 37: 1055-1059
50. Laude-Sharp M, Caroff M, Simard L et al. Induction of IL-1 during hemodialysis transmembrane passage of intact endotoxins LPS. Kidney Int 1990; 38: 1089-1094
51. Cannon JG, Tompkins RG, Gelfand JA et al. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Inf Dis 1990; 161: 79-84
52. Ziegler-Heitbock HW. Molecular mechanism in tolerance to lipopolysaccharide. J Inflamm 1995; 45: 13-26